Efficacy and Safety of First-Line Chemoimmunotherapy with Durvalumab or Atezolizumab in Extensive-Stage of Small-Cell Lung Cancer in Real World Practice
: Background: Small-cell lung cancer (SCLC) is characterised by an aggressive clinical course and the early development of distant metastases. The introduction of immune checkpoint inhibitors to platinum-based chemotherapy has significantly improved survival outcomes. The aim of this study was to compare the efficacy a...